• About us
  • Advertise
  • Contact
  • Nominate
  • Client’s Voice
  • Login
  • Register
📖 Magazine
The Global Economics
  • Home
  • Banking
  • Non Banking
  • Markets
  • Infrastructure
  • Lifestyle
  • FeatureNew
  • Awards
No Result
View All Result
  • Home
  • Banking
  • Non Banking
  • Markets
  • Infrastructure
  • Lifestyle
  • FeatureNew
  • Awards
No Result
View All Result
The Global Economics
No Result
View All Result
Home Infrastructure Healthcare

Xvivo Perfusion AB shares surge 15% post pig to human heart transplant

Shares of Xvivo Perfusion AB were the best performing on the Stockholm All-Shares Index on 11th January

Sakshi K S by Sakshi K S
January 12, 2022
in Healthcare, Brokerage, The Global Economics, Top Stories
Reading Time: 2 mins read
0
Xvivo Perfusion AB shares surge 15% post pig to human heart transplant

Xvivo Perfusion AB shares surge 15% post pig to human heart transplant

34
SHARES
189
VIEWS
FacebookTwitterRedditWhatsAppLinkedInFacebook

Shares of Xvivo Perfusion AB, a Swedish MedTech firm, surged as much as 15% on 11th January 2022 following the news of its connection in the world’s foremost ever pig-to-human heart transplant.

Machinery enhanced by Xvivo Perfusion AB assisted surgeons at the University of Maryland Medical Centre to efficaciously transplant an inherently modified pig’s heart into a 57-year-old man last Friday, according to the firm.

Xvivo Perfusion AB’s Chief Executive Dag Andersson told Bloomberg that he never imagined that it would occur so soon. Andersson stated that the technology exceeded everybody’s expectations.

Andersson stated that the radical procedure, dubbed as xenotransplant, depended on Xvivo Perfusion AB’s technology and that a surgical team in Europe was now facilitating a similar project to the one accomplished in the United States of America.

Human-to-human transplants have already been simplified by utilizing the Xvivo Perfusion AB methodology in clinical trials and the product has begotten a ‘Breakthrough Device Designation’ from American regulators. The CEO stated that they could not wait to commercialize that technology.

Xvivo’s shares were the best performing on the Stockholm All-Shares Index on 11th January, allowing its market worth to rise to USD 926 million.

About Xvivo Perfusion AB

Xvivo is a medical technology firm with headquarters in Gothenburg, Sweden, a production house in Lund, Sweden, and an office in Denver, USA. The firm is cemented into medical science and their core business elaborates ex vivo organ preservation. The firm focuses on enhancing augmented solutions for tissue, cell, and organ preservation and perfusion relating to transplantation. The firm boasts over two decades of experience within the transplant industry and are devoted to providing effective and clinically proven products that both enhance the accessibility to acceptable donor organs and enhance survival post-transplantation procedures.

Via: Short URL
Tags: pig-to-human heart transplantStockholm All-Shares IndexUniversity of Maryland Medical CentreXvivo Perfusion AB
Sakshi K S

Sakshi K S

Sakshi is a professional content writer engaging readers with gripping business news stories.

Related Posts

Indonesian Parliament Approves $216 Billion State Budget
Economy

Indonesian Parliament Approves $216 Billion State Budget

by Riya Thomas
September 21, 2023
Changing Geopolitics of Azerbaijan & Armenia and Its Effects on the World Economy
Economy

Changing Geopolitics of Azerbaijan & Armenia and Its Effects on the World Economy

by The Global Economics
September 20, 2023
Toyota's Bold Move: Fusing Traditional Tactics and Cutting-Edge Technology in the EV Arena
Transportation

Toyota’s Bold Move: Fusing Traditional Tactics and Cutting-Edge Technology in the EV Arena

by Riya Thomas
September 19, 2023
China’s Trade War Expands Beyond Semiconductors
Lifestyle

China’s Trade War Expands Beyond Semiconductors 

by The Global Economics
September 19, 2023
Apple's Annual Launch Event 2023 - iPhone 15, Apple Watch Ultra 2, and More 
Technology

Apple’s Annual Launch Event 2023 – iPhone 15, Apple Watch Ultra 2, and More 

by The Global Economics
September 18, 2023
Twitter Youtube LinkedIn Soundcloud
the global economics logo

The Global Economics Limited is a UK based financial publication and a quarterly business magazine giving thoughtful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.

DMCA.com Protection Status

  • Privacy
  • Legal
  • Terms of Use
  • Client’s Voice
  • Server Status

norton verified - the global economics

Latest Posts

UK Banks Announce Closure of 36 More Branches

UK Banks Announce Closure of 36 More Branches

September 22, 2023
Indonesian Parliament Approves $216 Billion State Budget

Indonesian Parliament Approves $216 Billion State Budget

September 21, 2023
Changing Geopolitics of Azerbaijan & Armenia and Its Effects on the World Economy

Changing Geopolitics of Azerbaijan & Armenia and Its Effects on the World Economy

September 20, 2023
Download The Global Economics PWA to your mobile or Desktop
PWA App Download
Download The Global Economics Android App to your mobile or Desktop
Android App
Download The Global Economics IOS App to your mobile or Desktop
IOS App

All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏

No Result
View All Result
  • About us
  • Awards
  • Magazine
  • Client’s Voice
  • Exclusive Coverage
  • Nominate
  • Login
  • Sign Up

All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏

Welcome Back!

Sign In with Facebook
Sign In with Linked In
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Facebook
Sign Up with Linked In
OR

Fill the forms below to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Go to mobile version